## Clinical Diagnosis: Intraductal Papilloma ### Key Diagnostic Features **High-Yield:** - **Spontaneous unilateral nipple discharge** = hallmark of intraductal pathology - **Greenish, non-bloody discharge** = benign (bloody discharge raises concern for malignancy) - **Subareolar mobile mass** = classic location for papilloma - **Benign cytology** = excludes malignancy - **Imaging unremarkable** = small papillomas may not be visible on mammography or ultrasound **Key Point:** Intraductal papilloma is the **most common benign cause of spontaneous unilateral nipple discharge** in women of reproductive and perimenopausal age. The discharge is typically non-bloody, greenish, or serous. ### Differential Diagnosis of Nipple Discharge | Feature | Intraductal Papilloma | DCIS | Duct Ectasia | Fibrocystic Change | |---------|----------------------|------|--------------|--------------------| | **Discharge type** | Non-bloody, green/serous | Bloody/serosanguinous | Thick, greenish | Bilateral, multiduct | | **Laterality** | Unilateral | Usually unilateral | Unilateral | Bilateral | | **Mass palpable** | Yes (subareolar) | May be absent | No discrete mass | Multiple nodules | | **Malignancy risk** | <5% (solitary), ~10% (multiple) | High (intraepithelial) | <1% | <1% | | **Imaging** | Often normal (small) | Microcalcifications, mass | Dilated ducts | Cysts, fibrosis | | **Management** | Duct excision if symptomatic | Excision + margins | Conservative | Conservative | **Clinical Pearl:** The distinction between **solitary** and **multiple** intraductal papillomas is crucial: - **Solitary papilloma:** <5% malignancy risk; duct excision is diagnostic and therapeutic - **Multiple papillomas:** ~10% malignancy risk; requires more aggressive follow-up and consideration of mastectomy ### Management Algorithm ```mermaid flowchart TD A[Unilateral nipple discharge]:::outcome --> B{Bloody or serosanguinous?}:::decision B -->|Yes| C[High suspicion for malignancy]:::urgent B -->|No| D[Benign discharge<br/>green/serous/clear]:::outcome C --> E[Duct excision<br/>with histopathology]:::action D --> F{Palpable mass?}:::decision F -->|Yes| G[Duct excision<br/>if symptomatic]:::action F -->|No| H[Clinical follow-up<br/>6-12 months]:::action E --> I{Papilloma found?}:::decision I -->|Yes, solitary| J[Excision complete<br/>Annual follow-up]:::outcome I -->|Yes, multiple| K[Higher malignancy risk<br/>Consider MRI/close follow-up]:::action I -->|No| L[Reassess for other pathology]:::action ``` ### Why This Is Intraductal Papilloma 1. **Spontaneous unilateral nipple discharge** in a premenopausal/perimenopausal woman is the classic presentation 2. **Non-bloody, greenish discharge** is typical; bloody discharge would raise suspicion for malignancy 3. **Subareolar mobile mass** is the characteristic location 4. **Benign cytology** excludes malignancy 5. **Imaging unremarkable** is expected for small papillomas ### Management Rationale **Key Point:** For a **solitary intraductal papilloma** with benign cytology and no imaging evidence of malignancy, the options are: 1. **Duct excision** (diagnostic + therapeutic) if symptomatic or for definitive diagnosis 2. **Clinical observation** if asymptomatic and cytology is clearly benign In this case, the patient is **symptomatic** (discharge), so **duct excision** is appropriate. However, if the question asks for management and the discharge is minimal, observation with clinical follow-up at 6–12 weeks is also acceptable as a first step, with duct excision reserved for persistent or worsening symptoms. **High-Yield:** If histopathology reveals **multiple papillomas** or **atypical papilloma**, the malignancy risk increases, and closer surveillance or mastectomy may be considered. ### Why Other Options Are Incorrect 1. **Observation alone without duct excision** — While observation is reasonable for asymptomatic patients, duct excision is the gold standard for diagnosis and symptom relief in symptomatic cases 2. **Immediate mastectomy** — Unjustified for a benign-appearing lesion with benign cytology; mastectomy is reserved for multiple papillomas or confirmed malignancy 3. **NSAIDs for fibrocystic change** — Fibrocystic change is typically bilateral with multiple cysts; this is unilateral with a discrete mass 4. **Wide local excision for phyllodes tumor** — Phyllodes tumors are rare, usually larger (>2 cm), and present as a palpable mass without nipple discharge [cite:Robbins 10e Ch 24]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.